These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34125864)

  • 21. Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
    Chen SMY; Wong YC; Yim LY; Zhang H; Wang H; Lui GCY; Li X; Tang X; Cheng L; Du Y; Peng Q; Wang J; Kwok HY; Huang H; Lau TT; Chan DPC; Wong BCK; Liu L; Chakrabarti LA; Lee SS; Chen Z
    J Virol; 2022 Apr; 96(7):e0216121. PubMed ID: 35297660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.
    Amara RR; Ibegbu C; Villinger F; Montefiori DC; Sharma S; Nigam P; Xu Y; McClure HM; Robinson HL
    Virology; 2005 Dec; 343(2):246-55. PubMed ID: 16185742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.
    Carnathan DG; Wetzel KS; Yu J; Lee ST; Johnson BA; Paiardini M; Yan J; Morrow MP; Sardesai NY; Weiner DB; Ertl HC; Silvestri G
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):518-23. PubMed ID: 25550504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral reservoir is suppressed but not eliminated by CD8 vaccine specific lymphocytes.
    Yin J; Dai A; Shen A; Lecureux J; Lewis MG; Boyer JD
    Vaccine; 2010 Feb; 28(8):1924-31. PubMed ID: 20188248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal and systemic SIV-specific cytotoxic CD4
    Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C
    Sci Rep; 2019 Apr; 9(1):5661. PubMed ID: 30952887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.
    Stebbings R; Berry N; Waldmann H; Bird P; Hale G; Stott J; North D; Hull R; Hall J; Lines J; Brown S; D'Arcy N; Davis L; Elsley W; Edwards C; Ferguson D; Allen J; Almond N
    J Virol; 2005 Oct; 79(19):12264-72. PubMed ID: 16160152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broadening of CD8+ cell responses in vaccine-based simian immunodeficiency virus controllers.
    Iwamoto N; Tsukamoto T; Kawada M; Takeda A; Yamamoto H; Takeuchi H; Matano T
    AIDS; 2010 Nov; 24(18):2777-87. PubMed ID: 21045637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies.
    Rollman E; Smith MZ; Brooks AG; Purcell DF; Zuber B; Ramshaw IA; Kent SJ
    J Immunol; 2007 Oct; 179(7):4571-9. PubMed ID: 17878354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.
    Tryniszewska E; Nacsa J; Lewis MG; Silvera P; Montefiori D; Venzon D; Hel Z; Parks RW; Moniuszko M; Tartaglia J; Smith KA; Franchini G
    J Immunol; 2002 Nov; 169(9):5347-57. PubMed ID: 12391256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
    J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.
    Chowdhury A; Hayes TL; Bosinger SE; Lawson BO; Vanderford T; Schmitz JE; Paiardini M; Betts M; Chahroudi A; Estes JD; Silvestri G
    J Virol; 2015 Sep; 89(17):8677-86. PubMed ID: 26063417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.
    Shacklett BL; Shaw KE; Adamson LA; Wilkens DT; Cox CA; Montefiori DC; Gardner MB; Sonigo P; Luciw PA
    J Virol; 2002 Nov; 76(22):11365-78. PubMed ID: 12388697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Immunogen Selectively Eliciting CD8
    Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys.
    Acierno PM; Schmitz JE; Gorgone DA; Sun Y; Santra S; Seaman MS; Newberg MH; Mascola JR; Nabel GJ; Panicali D; Letvin NL
    J Immunol; 2006 May; 176(9):5338-45. PubMed ID: 16622001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
    Ourmanov I; Brown CR; Moss B; Carroll M; Wyatt L; Pletneva L; Goldstein S; Venzon D; Hirsch VM
    J Virol; 2000 Mar; 74(6):2740-51. PubMed ID: 10684290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.
    Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK
    Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.